Arteris, Inc. (NASDAQ:AIP - Get Free Report) CFO Nicholas B. Hawkins sold 5,638 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $9.50, for a total transaction of $53,561.00. Following the completion of the sale, the chief financial officer now owns 156,299 shares in the company, valued at approximately $1,484,840.50. The trade was a 3.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Arteris Price Performance
Shares of AIP traded up $0.11 during mid-day trading on Friday, reaching $9.69. The company had a trading volume of 1,657,907 shares, compared to its average volume of 223,655. The company's 50 day simple moving average is $7.65 and its 200 day simple moving average is $8.59. Arteris, Inc. has a 1-year low of $5.46 and a 1-year high of $12.64. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $406.79 million, a price-to-earnings ratio of -11.82 and a beta of 1.37.
Institutional Investors Weigh In On Arteris
A number of hedge funds have recently made changes to their positions in the stock. Needham Investment Management LLC boosted its stake in shares of Arteris by 2.5% in the 1st quarter. Needham Investment Management LLC now owns 2,812,500 shares of the company's stock valued at $19,434,000 after purchasing an additional 67,500 shares in the last quarter. Samjo Management LLC increased its position in Arteris by 0.9% in the 4th quarter. Samjo Management LLC now owns 1,157,250 shares of the company's stock valued at $11,792,000 after acquiring an additional 10,000 shares during the period. Acadian Asset Management LLC increased its position in Arteris by 40.6% in the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after acquiring an additional 260,277 shares during the period. Next Century Growth Investors LLC raised its stake in shares of Arteris by 46.4% during the first quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock valued at $2,817,000 after acquiring an additional 129,143 shares during the last quarter. Finally, Federated Hermes Inc. lifted its holdings in shares of Arteris by 97.2% during the first quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after purchasing an additional 161,241 shares during the period. 64.36% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, Rosenblatt Securities restated a "buy" rating and issued a $14.00 price target on shares of Arteris in a research note on Wednesday, May 21st.
View Our Latest Stock Analysis on AIP
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.